123I-ATT001

Iodine-123 ATT001 radiopharmaceutical · Theragnostics Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 123I-ATT001, covering 2026-03-31 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Open-label Study of 123I-ATT001 in Subjects With Relapsed Glioblastoma [Phase 1]